Into 2021 Medtechs Prioritize Third-Wave Coronavirus Readiness

If Necessity Is The Mother Of Invention, Then Healthtech Firms Know What Is Expected Of Them In 2021 – How They Achieve It Will Be Anything But Straightforward

Coronavirus has definitively changed health care delivery and the perceptions of health technologies and digital ecosystems. Industry will need to adjust to the aftermath of COVID-19, take opportunities and learn lessons from 2020 or 2021 could be every inch as challenging.

Covid 19
• Source: Shutterstock

Before the first wave of the pandemic had tailed off and the second wave fears were not yet borne out, MassMutual Ventures’ Ryan Collins expressed a regret: he wished that that his Asia-focused venture capital firm had done more deals going into 2020, before the coronavirus first slowed business, and then changed the way it had to be done.

Collins, a partner at the Singapore-based branch of MMV, was addressing an In Vivo-hosted panel at the APACMed annual conference,...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Deal-Making

More from In Vivo